company background image
4127 logo

Tien Liang BioTech TPEX:4127 Stock Report

Last Price

NT$36.10

Market Cap

NT$1.7b

7D

-4.7%

1Y

143.9%

Updated

17 Jul, 2024

Data

Company Financials

Tien Liang BioTech Co., Ltd.

TPEX:4127 Stock Report

Market Cap: NT$1.7b

4127 Stock Overview

Manufactures and sells pharmaceutical products in Taiwan and internationally.

4127 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends1/6

Tien Liang BioTech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tien Liang BioTech
Historical stock prices
Current Share PriceNT$36.10
52 Week HighNT$47.80
52 Week LowNT$13.25
Beta0.65
11 Month Change-12.91%
3 Month Change3.29%
1 Year Change143.92%
33 Year Change240.57%
5 Year Change308.37%
Change since IPO61.38%

Recent News & Updates

Recent updates

Is Tien Liang BioTech (GTSM:4127) Using Too Much Debt?

Apr 19
Is Tien Liang BioTech (GTSM:4127) Using Too Much Debt?

Tien Liang BioTech (GTSM:4127) Is Carrying A Fair Bit Of Debt

Jan 04
Tien Liang BioTech (GTSM:4127) Is Carrying A Fair Bit Of Debt

Shareholder Returns

4127TW PharmaceuticalsTW Market
7D-4.7%-0.8%0.4%
1Y143.9%16.5%37.6%

Return vs Industry: 4127 exceeded the TW Pharmaceuticals industry which returned 16.5% over the past year.

Return vs Market: 4127 exceeded the TW Market which returned 37.6% over the past year.

Price Volatility

Is 4127's price volatile compared to industry and market?
4127 volatility
4127 Average Weekly Movement8.2%
Pharmaceuticals Industry Average Movement4.5%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.5%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 4127's share price has been volatile over the past 3 months.

Volatility Over Time: 4127's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
196062Min-Chung Chiwww.tlb.com.tw

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, low back pain, sore feet, dizziness, thirst, dry tongue, sore throat, and heel pain, as well as rheumatism, joint pain, traveling pain, wind-cold-dampness, gout, neuralgia, enuresis, hemorrhoids, constipation, athlete’s foot, fall injuries, cold, bronchitis, cough, and phlegm indications. It provides western medicine products, including ointment, hair removal cream, tablet, capsule, soreness spray, and pain patch products, as well as pain relief gels.

Tien Liang BioTech Co., Ltd. Fundamentals Summary

How do Tien Liang BioTech's earnings and revenue compare to its market cap?
4127 fundamental statistics
Market capNT$1.65b
Earnings (TTM)NT$18.80m
Revenue (TTM)NT$452.77m

87.9x

P/E Ratio

3.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4127 income statement (TTM)
RevenueNT$452.77m
Cost of RevenueNT$170.67m
Gross ProfitNT$282.11m
Other ExpensesNT$263.31m
EarningsNT$18.80m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.41
Gross Margin62.31%
Net Profit Margin4.15%
Debt/Equity Ratio14.0%

How did 4127 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

122%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.